Eiger BioPharmaceuticals (EIGR) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-7.5
-5.11
-2.71
-0.32

Details

Expected EPS
-4.2
Actual EPS
N/A
Surprise EPS
4.2
Surprise Percent
+100%

Description

Eiger BioPharmaceuticals (EIGR) will report earnings of for Q2 2024 on May 09, 2024.

0 Comments

Share your thoughts